Complementary and Alternative Medicines in the Management of Heart Failure: A Scientific Statement From the American Heart Association | Circulation
Coronary Heart Disease Diagnostic Imaging Devices Market Outlook To 2030: Innovations And Aging Demographics Drive 7% CAGR
The coronary heart disease diagnostic imaging devices market is projected to grow at a CAGR of ~7% over the forecast period. Major factors driving growth include the rising prevalence of coronary heart diseases, growth in the geriatric population, technological advancements in imaging devices, growing demand for non-invasive diagnostic techniques, adoption of sedentary lifestyles worldwide, rising awareness and early diagnosis of coronary heart disease, and increased R&D investments and grants for cardiovascular research.
Explore market trends, size, share and growth report - request a sample copy: https://meditechinsights.Com/coronary-heart-disease-diagnostic-imaging-devices-market/
Coronary Heart Disease (CHD) diagnostic imaging devices are medical technologies designed to generate detailed images of the heart, aiding in the diagnosis of CHD, a condition caused by plaque buildup in the coronary arteries, leading to reduced blood flow. These devices enable healthcare professionals to examine heart structures, evaluate blood circulation, and identify blockages or abnormalities in the coronary arteries. CHD diagnostic imaging technologies include X-ray machines, CT scanners, MRIs, and other advanced imaging systems that provide clear visualization of the heart and blood vessels.
Growing demand for non-invasive diagnostic techniques fuels its demand
With continuous technological advancements, non-invasive imaging has become essential not only for diagnosing Coronary Heart Disease (CHD) but also for guiding treatment decisions, assessing prognosis, and optimizing cost-effective, value-based care. Unlike traditional invasive procedures such as catheter-based coronary angiography, which pose risks of complications, extended recovery times, and higher medical expenses, advanced non-invasive imaging techniques including CT Coronary Angiography (CCTA), Cardiac MRI, Echocardiography, and Nuclear Imaging—offer safer, faster, and more precise diagnostic solutions. These modalities provide both functional and anatomical insights into coronary artery blockages, blood flow, and heart function, allowing for accurate disease assessment without surgical intervention. With increasing awareness of early CHD detection, growing healthcare investments, and the expanding use of AI-powered imaging technologies, demand for non-invasive diagnostic imaging is expected to rise significantly, further driving market growth.
Rising prevalence of CHD drives market growth
Coronary Heart Disease (CHD) is the most prevalent cardiovascular disease (CVD), causing nearly 9 million deaths annually, as reported by the World Health Organization (WHO). Its rising incidence is driven by factors such as an aging population, increasing obesity rates, diabetes, and hypertension. Additionally, urbanization and modern lifestyle changes have contributed to higher stress levels, unhealthy diets, and reduced physical activity, further elevating CHD risk. Since CHD often develops silently, with symptoms emerging in later stages, early detection through CHD imaging devices is essential. Accurate and timely diagnosis enables healthcare providers to make well-informed decisions, improving patient care by facilitating the development of optimal treatment plans. Furthermore, CHD imaging devices play a crucial role in monitoring disease progression, assessing treatment effectiveness, and detecting other cardiovascular conditions, fueling their growing demand.
Competitive Landscape Analysis
The global coronary heart disease diagnostic imaging devices market is marked by the presence of established and emerging market players such as Canon Medical Systems; Esaote SPA; FUJIFILM Holdings Corporation; GE Healthcare; Hitachi Medical Corporation; Koninkilijhe Phillips N. V.; SAMSUNG; Siemens Healthineers AG; Ziehm Imaging GmbH; Carestream Health; Shimadzu Corporation; Bracco Imaging S.P.A.; and Hologic, Inc.; among others. Some of the key strategies adopted by market players include new product development, strategic partnerships and collaborations, and investments.
Explore the latest trends and deep insights in just one click: https://meditechinsights.Com/coronary-heart-disease-diagnostic-imaging-devices-market/
Global Coronary Heart Disease Diagnostic Imaging Devices Market Segmentation
This report by Medi-Tech Insights provides the size of the global coronary heart disease diagnostic imaging devices market at the regional- and country-level from 2023 to 2030. The report further segments the market based on modality and end user.
Market Size & Forecast (2023-2030), By Modality, USD Million
Market Size & Forecast (2023-2030), By End User, USD Million
Market Size & Forecast (2023-2030), By Region, USD Million
Autoimmune Disease Diagnosis Market Set for Rapid Growth, Size, Share, and Forecast
Neurodiagnostics Market: Industry Share, Size, Growth Projections, and Technological Innovations
HIV Diagnostics Market Size, Share and Innovative Trends and Transformative Forces
About Medi-Tech Insights
Medi-Tech Insights is a healthcare-focused business research & insights firm. Our clients include Fortune 500 companies, blue-chip investors & hyper-growth start-ups. We have completed 100+ projects in Digital Health, Healthcare IT, Medical Technology, Medical Devices & Pharma Services in the areas of market assessments, due diligence, competitive intelligence, market sizing and forecasting, pricing analysis & go-to-market strategy. Our methodology includes rigorous secondary research combined with deep-dive interviews with industry-leading CXO, VPs, and key demand/supply side decision-makers.
Contact:
Ruta HaldeAssociate, Medi-Tech InsightsPhone: +32 498 86 80 79Email: info@meditechinsights.ComWebsite: https://meditechinsights.Com/
Risk Scores Accurately Predicted Heart Attacks, Study Finds. With CT Scans, They Did Even Better
In what researchers hope could be a case of 1 + 1 = 3, new research suggests that combining a model to predict 10-year cardiovascular risk with an imaging test of coronary arteries could be better than either method alone at identifying people in danger of their first heart attack.
The model is PREVENT, which computes a risk score based on measures familiar from the primary care office: blood pressure, cholesterol levels, kidney function, age, and BMI, as well as questions about type 2 diabetes, smoking, and social determinants of health. The imaging test is a CT scan that detects calcium buildup in arteries leading to the heart. High amounts of calcium, alone and inside fatty plaques, can lead to blockages and heart attacks.
CT scans yield a coronary artery calcium score that might be the reason for prescribing a statin or more medications to lower cholesterol.
The value of combining the two predictors of heart disease lies in revealing risk before symptoms show up, the study authors said. The difference between solo and combined scores was modest.
"It's not always clear who should be screened for coronary calcium; thus, we decided to see if the PREVENT score could be used in this novel manner," Morgan Grams of New York University's Grossman School of Medicine told STAT. She is an author of the study published Wednesday in the Journal of the American Heart Association. "Once we determined that it could, we assessed whether the coronary calcium score could add information to PREVENT in the prediction of incident cardiovascular disease. It did."
New model enables simpler, cheaper estimate of heart failure riskTo arrive at this conclusion, the researchers used real-world evidence, in this case the medical records of nearly 7,000 people in New York who were referred for cardiovascular disease screening. The PREVENT model sorted people by low, mildly elevated, moderately elevated, or high risk of heart attack. Those scores matched what CT scans estimated for risk, but when the scores were combined, they more accurately identified the participants who were at slightly higher risk and who had a heart attack in the following year.
"Both are valid measures of cardiovascular disease risk and might be used together to better risk stratify patients," Grams said.
Timothy Anderson, a primary care physician at University of Pittsburgh Medical Center, isn't so sure CT scans would prove to be sufficiently better at predicting heart attacks than the PREVENT score alone, given imaging's cost (starting at around $300), concern about radiation exposure, and the lack of a recommendation from the U.S. Preventive Services Task Force to use it as a screening test.
While not disputing the value of measuring coronary artery calcium in some cases, he said the study subjects weren't typical of patients in primary care whose risk can be identified by PREVENT. And the improvement when doing both tests was modest, on the order of 1% or 2%.
"People who get coronary artery calciums are not run-of-the-mill folks," he told STAT. "I think the challenge comes with how much more useful that is than the usual stuff that we already do in clinic, like checking someone's blood pressure and cholesterol and knowing their age."
Cardiologists might use calcium artery scores for patients already taking statins who may need an additional cholesterol medicine, Anderson said, or as more information for patients on the fence about starting a statin.
A high coronary artery calcium score is a strong sign of high risk for cardiovascular events, while a low score is a sign that a problem is unlikely in the next five to seven years.
"The PREVENT score is a useful predictor of cardiovascular events, while coronary artery calcium scores are a sign of subclinical coronary artery disease," Anderson said about unseen problems. "And that in and of itself is even more predictive of having events like heart attacks."
The PREVENT model, released by the American Heart Association in 2023, is not yet officially adopted as a guideline for practice by two medical societies still reviewing them. Formally known as Predicting Risk of cardiovascular disease EVENTs, it was intended to improve on a version created in 2013, known as the Pooled Cohort Equations and widely criticized for overestimating risk. The American Heart Association and American College of Cardiology review is expected to be completed next year.
PREVENT drew on billing and electronic health record data from a more diverse real-world population than the older one, incorporating current statin use as well as metabolic and kidney diseases. It has drawn attention for potentially narrowing the number of people who qualify for a statin, but the jury is still out.
Meanwhile, most people who would be advised to take statin, by either model, don't.
STAT's coverage of chronic health issues is supported by a grant from Bloomberg Philanthropies. Our financial supporters are not involved in any decisions about our journalism.
Heart Disease News
May 15, 2025 — A study reveals that inflammation associated with Marfan syndrome increases vulnerability to neurological diseases and complications following strokes, as demonstrated in animal ...
May 15, 2025 — A new study shows that the sinoatrial node (SAN) -- a small but powerful structure in the human heart that serves as its natural pacemaker and initiates every normal heartbeat -- runs on different ...
May 14, 2025 — Magnetic resonance imaging (MRI) scans of the heart could help to detect a life-threatening heart disease and enable clinicians to better predict which patients are most at risk, according to a new ...
May 14, 2025 — The risk of death or complications from the stress-related heart condition associated with stressful events, such as the death of a loved one -- called Takotsubo cardiomyopathy or broken heart ...
May 14, 2025 — We might have another reason to enjoy our daily cup of tea or small piece of dark chocolate, as a new study has found that naturally occurring compounds called flavan-3-ols -- found in cocoa, tea, ...
May 13, 2025 — Experts are urging people, especially those with existing heart or vascular conditions, to seek medical advice before attempting to lose weight using water-only fasting ...
May 13, 2025 — Researchers have identified the origin of cardiac cells using 3D images of a heart forming in real-time, inside a living mouse ...
May 9, 2025 — New research shows that the gum disease bacterium P. Gingivalis can slip into the bloodstream and infiltrate the heart. There, it quietly drives scar tissue buildup -- distorting the heart's ...
May 8, 2025 — Engineers created a new point-of-care test that measures cortisol in saliva to help doctors diagnose depression and ...
May 8, 2025 — A new study puts the spotlight on the rising burden of ischemic heart disease across Southeast Asia, East Asia and Oceania, and calls for localized, equity-focused interventions in these regions. The ...
May 8, 2025 — Even a few nights with insufficient sleep promote molecular mechanisms linked to a greater risk of heart problems. This has been shown in a new study in which the researchers investigated how sleep ...
May 8, 2025 — Researchers have developed cutting-edge MRI technology to diagnose a common heart problem more quickly and accurately than ever before. Aortic stenosis is a progressive and potentially fatal ...
May 7, 2025 — Healthy hearts are adaptable, and heartbeats exhibit complex variation as they adjust to tiny changes in the body and environment. Researchers have applied a new way to measure the complexity of ...
May 5, 2025 — People who are given a vaccine for shingles have a 23% lower risk of cardiovascular events, including stroke, heart failure, and coronary heart disease, according to a recent study of more than a ...
May 2, 2025 — The Haenyeo, a group of all-female divers from the Korean island of Jeju, are renowned for their ability to dive in frigid waters without the aid of breathing equipment -- even while pregnant. A ...
May 1, 2025 — Researchers have developed a revolutionary new way to find out the 'true age' of your heart using MRI. A new study shows how an MRI scan can reveal your heart's functional age -- and ...
Apr. 30, 2025 — Every second counts when it comes to detecting and treating heart attacks. A new technology may be able to identify heart attacks faster and more accurately than traditional ...
Apr. 30, 2025 — Childhood trauma significantly increases the likelihood of engaging in harmful alcohol consumption, smoking and illicit drug use, by the age of ...
Apr. 30, 2025 — Investigators have discovered a new pathway that may lead to a treatment for high blood pressure and aortic aneurysms. By creating a new laboratory model for studying these conditions, the team ...
Apr. 29, 2025 — Daily exposure to certain chemicals used to make plastic household items could be linked to more than 356,000 global deaths from heart disease in 2018 alone, a new analysis of population surveys ...
Comments
Post a Comment